113 related articles for article (PubMed ID: 20823407)
1. Gastroduodenal ulcerations as a delayed complication of hepatic metastasis radioembolization.
Nair J; Liu C; Caridi J; Zlotecki R; George TJ
J Clin Oncol; 2010 Dec; 28(35):e735-6. PubMed ID: 20823407
[No Abstract] [Full Text] [Related]
2. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.
Murthy R; Brown DB; Salem R; Meranze SG; Coldwell DM; Krishnan S; Nunez R; Habbu A; Liu D; Ross W; Cohen AM; Censullo M
J Vasc Interv Radiol; 2007 Apr; 18(4):553-61; quiz 562. PubMed ID: 17446547
[TBL] [Abstract][Full Text] [Related]
3. Gastroduodenal injury after radioembolization of hepatic tumors.
Carretero C; Munoz-Navas M; Betes M; Angos R; Subtil JC; Fernandez-Urien I; De la Riva S; Sola J; Bilbao JI; de Luis E; Sangro B
Am J Gastroenterol; 2007 Jun; 102(6):1216-20. PubMed ID: 17355414
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
5. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
Salem R; Thurston KG
J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
[TBL] [Abstract][Full Text] [Related]
6. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
[TBL] [Abstract][Full Text] [Related]
7. A first report of radioembolization for hepatic metastases from ocular melanoma.
Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
[TBL] [Abstract][Full Text] [Related]
8. Practical vascular anatomy in the preparation of radioembolization.
Paprottka PM; Jakobs TF; Reiser MF; Hoffmann RT
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):454-62. PubMed ID: 21567273
[TBL] [Abstract][Full Text] [Related]
9. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
10. Microdosimetric considerations of hepatic radioembolization.
Feinendegen LE
J Nucl Med; 1994 Oct; 35(10):1644-6. PubMed ID: 7931663
[No Abstract] [Full Text] [Related]
11. Selective internal radiation therapy: a case of SIR-Sphere associated duodenal ulceration.
Newland LR; Walsh A; Gilbert DR; Buckland ME
Pathology; 2007 Oct; 39(5):526-8. PubMed ID: 17886108
[No Abstract] [Full Text] [Related]
12. Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome.
Hoffman MA; Rubin JI; Vinceguerra VP; Nowakowski FS; Warner RR
J Vasc Interv Radiol; 2008 Jul; 19(7):1099-102. PubMed ID: 18589326
[No Abstract] [Full Text] [Related]
13. Selective internal radiation therapy-induced extrahepatic injury: an emerging cause of iatrogenic organ damage.
Crowder CD; Grabowski C; Inampudi S; Sielaff T; Sherman CA; Batts KP
Am J Surg Pathol; 2009 Jul; 33(7):963-75. PubMed ID: 18852678
[TBL] [Abstract][Full Text] [Related]
14. Yttrium-90 Microsphere Selective Internal Radiation Therapy-Induced Cholecystitis.
Pantaleon Vasquez R; Karamchandani DM
Int J Surg Pathol; 2020 Sep; 28(6):649-650. PubMed ID: 31830831
[No Abstract] [Full Text] [Related]
15. Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization.
Lam MGEH; Banerjee S; Louie JD; Abdelmaksoud MHK; Iagaru AH; Ennen RE; Sze DY
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1536-1547. PubMed ID: 23435742
[TBL] [Abstract][Full Text] [Related]
16. The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Neff R; Abdel-Misih R; Khatri J; Dignazio M; Garcia M; Petrelli N; Wilson P
Cancer Invest; 2008 Mar; 26(2):173-7. PubMed ID: 18259948
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia following 90Yttrium glass microsphere liver radioembolization.
Gundavaram P; Gaba RC
South Med J; 2011 Apr; 104(4):286. PubMed ID: 21606701
[No Abstract] [Full Text] [Related]
18. Gastroduodenal ulceration after selective internal radiation therapy of liver tumor.
Wallstabe I; Bakos G; Plötner A; Kretzschmar A; Wegner D; Hohdorf K; Scheibe J
Endoscopy; 2012; 44 Suppl 2 UCTN():E354-5. PubMed ID: 23012018
[No Abstract] [Full Text] [Related]
19. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
20. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
Powerski MJ; Scheurig-Münkler C; Banzer J; Schnapauff D; Hamm B; Gebauer B
Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
